Pneumonia
Conditions
Keywords
procalcitonin, antimicrobial stewardship, pneumonia
Brief summary
The goal of the study is to determine the impact of procalcitonin (PCT)-guided therapy on duration of antibiotic therapy in critical care unit (CCU) patients with suspected pneumonia at Mayo Clinic Health System Eau Claire.
Interventions
OTHERUse of procalcitonin as biomarker to guide therapy
Sponsors
Mayo Clinic
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 18 years old * admitted to critical care unit * placed on pneumonia protocol
Exclusion criteria
* patients who received outpatient antibiotic therapy within previous 21 days
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Length of antibiotic therapy | Indefinite | Participants will be followed for the entire time they are on antibiotics to treat pneumonia, an expected average of 30 total antibiotic days. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Length of stay in critical care unit | Indefinite | Participants will be followed for their entire length of stay in the critical care unit, an expected average of 7 days. |
| Cost | Once | The average cost of antibiotics per patient, measured in US dollars, based on total antibiotic days. |
| Length of stay in the hospital | Indefinite | Participants will be followed their entire length of stay in the hospital, an expected average of 14 days. |
Countries
United States
Outcome results
None listed